Claims
- 1. A pyrrolotriazole compound represented by formula (I) below: wherein X represents a member selected from the group consisting of a hydrogen atom, halogen atom, alkyloxy group, aryloxy group, acyloxy group, alkylsulfonyloxy and arylsulfonyloxy group, acylamino group, alkylsulfonamide and arylsulfonamide group, alkyloxycarbonyloxy group, aryloxycarbonyloxy group, alkylthio group, arylthio group, heterocyclic thio group, carbamoylamino group, carbamoyloxy group, heterocyclic carbonyloxy group, 5- or 6-membered nitrogen-containing heterocyclic group, imide group; and arylazo group; each of R1 and R2 represents an electron-attracting group having a Hammett's substituent constant p value of not less than 0.20, the sum of the p values of R1 and R2 being not less than 0.65; and each of G1 and G2 represents a nitrogen atom or a substituent represented by formula (II), provided that one of G1 and G2 being a nitrogen atom and the other being a substituent represented by formula (II) below: wherein R3 represents a member selected from the group consisting of a substituted or nonsubstituted alkyl group, substituted or nonsubstituted alkenyl group, substituted or nonsubstituted alkynyl group, substituted or nonsubstituted cycloalkyl group, substituted or nonsubstituted cycloalkenyl group, substituted or nonsubstituted aryl group, and substituted or nonsubstituted heterocyclic group; R4 represents a hydrogen atom or a substituent bonded by a carbon atom, R3 and R4 being capable of combining to form a ring; R5 represents a substituent, and n represents an integer of 0 to 4,provided that a group represented by R1, R2, R3, R4, R5, or X may be a divalent group, and thereby the coupler represented by formula (I) may form a polymer, which is a dimer or a higher-order polymer, or may form a homopolymer or a copolymer by combining with a polymeric chain.
- 2. The pyrrolotriazole compound according to claim 1, wherein the compound represented by formula (I) is represented by formula (III) below: wherein X represents a member selected from the group consisting of a hydrogen atom, halogen atom, 1- to 32-carbon alkyloxy group, 6- to 32-carbon aryloxy group, 1- to 32-carbon alkylthio group, 6- to 32-carbon arylthio group, 2- to 32-carbon heterocyclic thio group, 2- to 32-carbon alkyloxycarbonyloxy group, 7- to 32-carbon aryloxycarbonyloxy group, 1- to 32-carbon carbamoyloxy group, 3- to 32-carbon heterocyclic carbonyloxy group, and 2- to 32-carbon, 5- or 6-membered nitrogen-containing heterocyclic group which bonds to a coupling active position by a nitrogen atom; each of R1 and R2 represents an electron-attracting group having a Hammett's substituent constant p value of not less than 0.20, the sum of the p values of R1 and R2 being not less than 0.65; R3 represents a member selected from the group consisting of a substituted or nonsubstituted alkyl group, substituted or nonsubstituted alkenyl group, substituted or nonsubstituted alkynyl group, substituted or nonsubstituted cycloalkyl group, substituted or nonsubstituted cycloalkenyl group, substituted or nonsubstituted aryl group, and substituted or nonsubstituted heterocyclic group; R4 represents a member selected from the group consisting of a hydrogen atom, substituted or nonsubstituted alkyl group, substituted or nonsubstituted alkenyl group, substituted or nonsubstituted alkynyl group, substituted or nonsubstituted cycloalkyl group, substituted or nonsubstituted cycloalkenyl group, substituted or nonsubstituted aryl group, substituted or nonsubstituted acyl group, substituted or nonsubstituted alkyloxycarbonyl group, substituted or nonsubstituted aryloxycarbonyl group and substituted or nonsubstituted carbamoyl group, R3 and R4 being capable of combining to form a ring; and each of R11 to R14 independently represents a hydrogen atom or a substituent.
- 3. The pyrrolotriazole compound according to claim 1, wherein the compound represented by formula (I) is represented by formula (IV) below: wherein X represents a member selected from the group consisting of a hydrogen atom, halogen atom, substituted or nonsubstituted alkylthio group, substituted or nonsubstituted arylthio group, substituted or nonsubstituted heterocyclic thio group, substituted or nonsubstituted alkyloxycarbonyloxy group, substituted or nonsubstituted aryloxycarbonyloxy group, substituted or nonsubstituted carbamoyloxy group, and substituted or nonsubstituted heterocyclic carbonyloxy group; R3 represents a member selected from the group consisting of a substituted or nonsubstituted alkyl group, substituted or nonsubstituted alkenyl group, substituted or nonsubstituted alkynyl group, substituted or nonsubstituted cycloalkyl group, substituted or nonsubstituted cycloalkenyl group, substituted or nonsubstituted aryl group, and substituted or nonsubstituted heterocyclic group; R4 represents a member selected from the group consisting of a hydrogen atom, substituted or nonsubstituted alkyl group, substituted or nonsubstituted alkenyl group, substituted or nonsubstituted alkynyl group, substituted or nonsubstituted cycloalkyl group, substituted or nonsubstituted cycloalkenyl group, and substituted or nonsubstituted aryl group, R3 and R4 being capable of combining to form a ring; R11 represents a member selected from the group consisting of a substituted or nonsubstituted acylamino group, substituted or nonsubstituted alkylsulfonylamino group, substituted or nonsubstituted arylsulfonylamino group, and nitro group; R12, R13, and R14 can be the same or different and each represents a member selected from the group consisting of a hydrogen atom, halogen atom, alkyl group, aryl group, heterocyclic group, cyano group, hydroxy group, nitro group, carboxy group, sulfo group, amino group, alkyloxy group, aryloxy group, acylamino group, alkylamino group, anilino group, ureido group, sulfamoylamino group, alkylthio group, arylthio group, alkyloxycarbonylamino group, sulfonamide group, carbamoyl group, sulfamoyl group, sulfonyl group, alkyloxycarbonyl group, heterocyclic oxy group, azo group, acyloxy group, carbamoyloxy group, silyloxy group, aryloxycarbonylamino group, imide group, heterocyclic thio group, sulfinyl group, phosphonyl group, aryloxycarbonyl group, and acyl group; R21, R22, R23, R24, and R25 can be the same or different and each represents a member selected from the group consisting of a hydrogen atom, substituted or nonsubstituted alkyl group, substituted or nonsubstituted alkenyl group, substituted or nonsubstituted alkynyl group, substituted or nonsubstituted cycloalkyl group, substituted or nonsubstituted cycloalkenyl group, and substituted or nonsubstituted aryl group; and Z represents a non-metallic atom group required to form a 5- to 8-membered ring, said ring being able to be substituted, be a saturated ring, or have a unsaturated bond.
- 4. The pyrrolotriazole compound according to claim 1,wherein X represents a member selected from the group consisting of a hydrogen atom, halogen atom, arylthio group, carbamoyloxy group, and heterocyclic carbonyloxy group; each of R1 and R2 represents a member selected from the group consisting of an acyl group, acyloxy group, carbamoyl group, alkyloxycarbonyl group, aryloxycarbonyl group, cyano group, nitro group, dialkylphosphono group, diarylphosphono group, diarylphosphinyl group, alkylsulfinyl group, arylsulfinyl group, alkylsulfonyl group, arylsulfonyl group, sulfonyloxy group, acylthio group, sulfamoyl group, thiocyanate group, thiocarbonyl group, alkyl halide group, alkoxy halide group, aryloxy halide group, alkylamino halide group, alkylthio halide group, aryl group which is substituted by another electron attracting group having a p value of 0.20 or more, heterocyclic group, halogen atom, azo group, and selenocyanate group; R3 represents a member selected from the group consisting of a substituted or nonsubstituted alkyl group, substituted or nonsubstituted alkenyl group, substituted or nonsubstituted alkynyl group, substituted or nonsubstituted cycloalkyl group, substituted or nonsubstituted cycloalkenyl group, substituted or nonsubstituted aryl group, and substituted or nonsubstituted heterocyclic group; R4 represents a member selected from the group consisting of a substituted or nonsubstituted alkyl group, substituted or nonsubstituted alkenyl group, substituted or nonsubstituted alkynyl group, substituted or nonsubstituted cycloalkyl group, substituted or nonsubstituted cycloalkenyl group, and substituted or nonsubstituted aryl group, R3 and R4 being capable of combining to form a ring; and R5 represents a member selected from the group consisting of an alkyl group, alkenyl group, alkynyl group, cycloalkyl group, cycloalkenyl group, aryl group, heterocyclic group, cyano group, nitro group, acylamino group, anilino group, ureido group, sulfamoylamino group, alkylthio group, arylthio group, alkyloxycarbonylamino group, sulfonamide group (alkylsulfonylamino group and arylsulfonylamino group), carbamoyl group, sulfamoyl group, sulfonyl group, alkyloxycarbonyl group, heterocyclic oxy group, acyloxy group, carbamoyloxy group, aryloxycarbonylamino group, imide group, heterocyclic thio group, sulfinyl group, phosphonyl group, aryloxycarbonyl group, and acyl group.
- 5. The pyrrolotriazole compound according to claim 2,wherein each of R11 to R14 independently represents a member selected from the group consisting of a hydrogen atom, halogen atom, alkyl group, alkenyl group, alkynyl group, cycloalkyl group, cycloalkenyl group, aryl group, heterocyclic group, cyano group, hydroxy group, nitro group, carboxy group, sulfo group, amino group, alkyloxy group, aryloxy group, acylamino group, alkylamino group, anilino group, ureido group, sulfamoylamino group, alkylthio group, arylthio group, alkyloxycarbonylamino group, sulfonamide group, carbamoyl group, sulfamoyl group, sulfonyl group, alkyloxycarbonyl group, heterocyclic oxy group, azo group, acyloxy group, carbamoyloxy group, silyloxy group, aryloxycarbonylamino group, imide group, heterocyclic thio group, sulfinyl group, phosphonyl group, aryloxycarbonyl group, and acyl group.
- 6. The pyrrolotriazole compound according to claim 5,wherein X represents a member selected from the group consisting of a hydrogen atom, halogen atom, arylthio group, carbamoyloxy group, and heterocyclic carbonyloxy group; each of R1 and R2 represents a member selected from the group consisting of an acyl group, acyloxy group, carbamoyl group, alkyloxycarbonyl group, aryloxycarbonyl group, cyano group, nitro group, dialkylphosphono group, diarylphosphono group, diarylphosphinyl group, alkylsulfinyl group, arylsulfinyl group, alkylsulfonyl group, arylsulfonyl group, sulfonyloxy group, acylthio group, sulfamoyl group, thiocyanate group, thiocarbonyl group, alkyl halide group, alkoxy halide group, aryloxy halide group, alkylamino halide group, alkylthio halide group, aryl group which is substituted by another electron attracting group having a p value of 0.20 or more, heterocyclic group, halogen atom, azo group, and selenocyanate group; R3 represents a member selected from the group consisting of a 1- to 32-carbon, straight-chain or branched-chain alkyl group, 7- to 32-carbon aralkyl group, 2- to 32-carbon alkenyl group, 2- to 32-carbon alkynyl group, 3- to 32-carbon cycloalkyl group, 3- to 32-carbon cycloalkenyl group, 6- to 36-carbon aryl group, and 5- to 8-membered, 1- to 36-carbon heterocyclic group having a nitrogen atom, oxygen atom, or sulfur atom; and R4 represents a member selected from the group consisting of a substituted or nonsubstituted alkyl group, substituted or nonsubstituted alkenyl group, substituted or nonsubstituted alkynyl group, substituted or nonsubstituted cycloalkyl group, substituted or nonsubstituted cycloalkenyl group, and substituted or nonsubstituted aryl group, R3 and R4 being capable of combining to form a ring.
- 7. The pyrrolotriazole compound according to claim 3, wherein X is a hydrogen atom; each of R21 and R22 is t-butyl; each of R23, R24, and R25 is a hydrogen atom; Z forms a cyclohexane ring, and the 4-position of this cyclohexane ring is substituted by a 1- to 8-carbon alkyl group; R3 and R4 form a ring structure; R11 is a substituted or nonsubstituted, 1- to 32-carbon alkylsulfonylamino group, substituted or nonsubstituted, 6- to 30-carbon arylsulfonylamino group, or nitro group; and each of R12 to R14 is a hydrogen atom or a 6- to 30-carbon arylsulfonylamino group having a substituent.
- 8. The pyrrolotriazole compound according to claim 7, wherein the substituent, which the arylsulfonylamino group has, is a 1- to 32-carbon alkoxy group, 1- to 32-carbon alkyl group, 1- to 32-carbon sulfonylamino group, 1- to 32-carbon acylamino group, or halogen atom.
- 9. The pyrrolotriazole compound according to claim 7, wherein R3 and R4 form a 6-membered ring bonded by a nitrogen atom.
- 10. The pyrrolotriazole compound according to claim 9, wherein the 6-membered ring bonded by a nitrogen atom is morpholino, piperadinyl substituted by an acyl group, or piperidino substituted by a carboxyl group.
Priority Claims (1)
Number |
Date |
Country |
Kind |
11-279838 |
Sep 1999 |
JP |
|
Parent Case Info
This application is a divisional of application Ser. No. 09/675,213, filed on Sep. 29, 2000, now U.S. Pat. No. 6,399,241 the entire contents of which are hereby incorporated by reference and for which priority is claimed under 35 U.S.C. §120; and this application claims priority of application Ser. No. 11-279838 filed in Japan on Sep. 30, 1999 under 35 U.S.C. §119.
US Referenced Citations (4)
Number |
Name |
Date |
Kind |
5256526 |
Suzuki et al. |
Oct 1993 |
A |
5756274 |
Matsuda et al. |
May 1998 |
A |
5994046 |
Kawai |
Nov 1999 |
A |
6132945 |
Saito et al. |
Oct 2000 |
A |
Foreign Referenced Citations (1)
Number |
Date |
Country |
0545300 |
Sep 1993 |
EP |
Non-Patent Literature Citations (1)
Entry |
Japanese patent application Kokai Publication No. 10-198009 (Partial English Translation) (Jul. 31, 1998). |